Tag results:
breast cancer cells
Extracellular Matrix News
Cysteine-Rich Domain of Type III Collagen N-Propeptide Inhibits Fibroblast Activation by Attenuating Tgfβ Signaling
[Matrix Biology] Scientists defined type III Collagen as a suppressor of scar formation and desmoplasia through its effects, in part, on myofibroblasts.
Extracellular Matrix News
Engineering Tumor Constructs to Study Matrix-Dependent Angiogenic Signaling of Breast Cancer Cells
[Biotechnology Progress] Scientists reported the development of an in vitro 3D breast cancer model to investigate the effect of stromal crosslinking and consequent, stiffening on the angiogenic activity of cancer cells.
Cancer Stem Cell News
Label-Free Enrichment of MCF7 Breast Cancer Cells from Leukocytes Using Continuous Flow Dielectrophoresis
[Electrophoresis] Scientists presented a continuous flow, antibody-free dielectrophoresis-based microfluidic device to concentrate MCF7 breast cancer cells, a well-established circulating tumor cells model, in the presence of leukocytes extracted from human blood samples.
Immune Regulation News
In Situ Imaging for Tumor Microbiome Interactions via Imaging Mass Cytometry on Single-Cell Level
[Cytometry Part A] Researchers developed a rapid semi-quantitative method for in situ imaging of bacteria and multiplex cell phenotypes on the same solid tumor tissue sections.
Mammary Cell News
PRMT5 Regulates RNA M6A Demethylation for Doxorubicin Sensitivity in Breast Cancer
[Molecular Therapy] Scientists found that doxorubicin treatment significantly induced RNA m6A methylation in breast cancer cells in both a dose- and time-dependent manner.
Mammary Cell News
YTHDF1 Promotes Breast Cancer Cell Growth, DNA Damage Repair, and Chemoresistance
[Cell Death & Disease] YTHDF1 facilitated S-phase entry, DNA replication and DNA damage repair, and accordingly YTHDF1 knockdown sensitized breast cancer cells to Adriamycin and Cisplatin as well as Olaparib, a PARP inhibitor.